• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低脂或高脂乳制品及乳制品衍生脂肪对代谢功能障碍相关脂肪性肝病的不同影响。

Differential effects of low or high-fat dairy and fat derived from dairy products on MASLD.

作者信息

Tirosh Oren, Verman Michal, Ivancovsky-Wajcman Dana, Grinshpan Laura Sol, Fliss-Isakov Naomi, Webb Muriel, Shibolet Oren, Kariv Revital, Zelber-Sagi Shira

机构信息

Institute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.

School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.

出版信息

JHEP Rep. 2024 Aug 22;6(11):101194. doi: 10.1016/j.jhepr.2024.101194. eCollection 2024 Nov.

DOI:10.1016/j.jhepr.2024.101194
PMID:39492926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530594/
Abstract

BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly related to nutrition. However, only a few human and animal studies have tested the association between MASLD and dairy consumption and the effect of milk fat on liver damage. Therefore, we aimed at testing the association between consumption of dairy product and the incidence of MASLD and fibrosis markers in humans, and the effect of milk fat other fats on MASLD in animal studies.

METHODS

A prospective 7-year follow-up cohort study was performed including baseline and follow-up fasting blood tests, liver evaluation and a face-to-face interview on health status and behaviour using structured questionnaires. MASLD was determined by ultrasonography or by controlled attenuation parameter (CAP), and liver fibrosis by FibroTest™ or FibroScan®. An animal study was performed in which 6-week-old C57BL/6j male mice were fed a high-fat diet (HFD) consisting of lard, soybean oil, and milk fat for 12 weeks. Metabolic impairment was assessed during the animal experiment, and serum advanced glycation end-products (AGEs) and liver damage were evaluated.

RESULTS

A total of 316 patients were included in the prospective cohort. In multivariable analysis, high consumption of low-medium fat low-sugar dairy products (g/day above the baseline sex-specific median) was associated with a lower risk for MASLD incidence (OR 0.42, 95% CI 0.18-0.95, 0.037) or incidence/persistence at follow-up (OR 0.58, 0.34-0.97, 0.039). Constantly high consumption of high-fat low-sugar dairy products was associated with greater odds for new onset/persistence of MASLD. Neither low-medium nor high-fat dairy consumption was related to fibrosis markers. In mice, all HFDs induced similar weight gain and steatosis and did not affect liver enzymes. Milk fat increases serum cholesterol and AGEs levels more than lard or soybean oil.

CONCLUSIONS

Low-medium fat low-sugar dairy products may be protective and should be preferred over high-fat dairy to prevent MASLD. HFDs from different fat sources with a wide spectrum of fatty acid saturation content are equally deleterious.

IMPACT AND IMPLICATIONS

MASLD is related to nutrition, but evidence of an association between high-fat and low-fat dairy products is lacking, therefore, we evaluated this association by performing experimental studies in mice and an observational human study. For MASLD prevention, a differential effect based on the type of dairy products should be considered: low-medium fat low-sugar dairy products were found to be protective, in contrast high-fat dairy and generally high-fat diets may be harmful. It would be advisable to prefer low-fat low-sugar dairy products and minimise intake of high-fat dairy products; however, additional evidence is needed to allow generalisability of our findings.

摘要

背景与目的

代谢功能障碍相关脂肪性肝病(MASLD)与营养密切相关。然而,仅有少数人体和动物研究检验了MASLD与乳制品消费之间的关联以及乳脂肪对肝损伤的影响。因此,我们旨在检验人类乳制品消费与MASLD发病率及纤维化标志物之间的关联,以及在动物研究中乳脂肪和其他脂肪对MASLD的影响。

方法

进行了一项为期7年的前瞻性队列研究,包括基线和随访时的空腹血液检测、肝脏评估,以及使用结构化问卷对健康状况和行为进行面对面访谈。通过超声检查或受控衰减参数(CAP)确定MASLD,通过FibroTest™或FibroScan®确定肝纤维化。进行了一项动物研究,给6周龄的C57BL/6j雄性小鼠喂食由猪油、大豆油和乳脂肪组成的高脂饮食(HFD),持续12周。在动物实验期间评估代谢损害,并评估血清晚期糖基化终产物(AGEs)和肝损伤情况。

结果

前瞻性队列共纳入316例患者。在多变量分析中,高消费中低脂肪低糖乳制品(高于基线性别特异性中位数的克/天)与较低的MASLD发病风险相关(OR 0.42,95%CI 0.18 - 0.95,P = 0.037)或随访时的发病率/持续存在率相关(OR 0.58,0.34 - 0.97,P = 0.039)。持续高消费高脂肪低糖乳制品与MASLD新发/持续存在的几率更高相关。中低脂肪或高脂肪乳制品消费均与纤维化标志物无关。在小鼠中,所有高脂饮食均导致相似的体重增加和脂肪变性,且不影响肝酶。乳脂肪比猪油或大豆油更能增加血清胆固醇和AGEs水平。

结论

中低脂肪低糖乳制品可能具有保护作用,在预防MASLD方面应优于高脂肪乳制品。来自不同脂肪来源、脂肪酸饱和度含量范围广泛的高脂饮食同样有害。

影响与意义

MASLD与营养相关,但缺乏高脂肪和低脂肪乳制品之间关联的证据,因此,我们通过在小鼠中进行实验研究和一项观察性人体研究来评估这种关联。对于MASLD的预防,应考虑基于乳制品类型的差异效应:发现中低脂肪低糖乳制品具有保护作用,相反,高脂肪乳制品和一般高脂饮食可能有害。建议优先选择低脂低糖乳制品并尽量减少高脂肪乳制品的摄入;然而,需要更多证据才能使我们的研究结果具有普遍性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/d89c4a1401f9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/587e389c59b1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/0591d05252b1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/d89c4a1401f9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/587e389c59b1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/0591d05252b1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3683/11530594/d89c4a1401f9/gr2.jpg

相似文献

1
Differential effects of low or high-fat dairy and fat derived from dairy products on MASLD.低脂或高脂乳制品及乳制品衍生脂肪对代谢功能障碍相关脂肪性肝病的不同影响。
JHEP Rep. 2024 Aug 22;6(11):101194. doi: 10.1016/j.jhepr.2024.101194. eCollection 2024 Nov.
2
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
3
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.低至中度饮酒与代谢功能障碍相关脂肪性肝病患者的纤维化增加有关。
J Hepatol. 2024 Dec;81(6):930-940. doi: 10.1016/j.jhep.2024.06.036. Epub 2024 Jul 4.
4
A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease.健康的生活方式与代谢功能障碍相关脂肪性肝病的发病风险降低呈前瞻性相关。
Hepatol Commun. 2024 Nov 4;8(11). doi: 10.1097/HC9.0000000000000583. eCollection 2024 Nov 1.
5
Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity.八周极低卡路里生酮饮食(VLCKD)对超重和肥胖患者代谢功能障碍相关脂肪性肝病(MASLD)的白细胞和血小板计数的影响。
Nutrients. 2023 Oct 21;15(20):4468. doi: 10.3390/nu15204468.
6
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.细胞核内的miR-204-3p可减轻小鼠代谢功能障碍相关脂肪性肝病。
J Hepatol. 2024 Jun;80(6):834-845. doi: 10.1016/j.jhep.2024.01.029. Epub 2024 Feb 6.
7
Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease.在代谢功能障碍相关脂肪性肝病中,胰腺内脂肪沉积与肝脏脂肪变性无关。
JHEP Rep. 2024 Jan 1;6(3):100998. doi: 10.1016/j.jhepr.2023.100998. eCollection 2024 Mar.
8
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.超重和肥胖代谢功能障碍相关脂肪性肝病患者极低卡路里生酮饮食 8 周前后肝脂肪变性和纤维化的性别差异。
Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408.
9
Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study.富含乳制品的饮食模式与代谢功能障碍相关脂肪性肝病的关系:来自韩国基因组与流行病学研究的结果。
Dig Liver Dis. 2024 Sep;56(9):1529-1536. doi: 10.1016/j.dld.2024.01.200. Epub 2024 Feb 8.
10
The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis.多成分药物复合肝制剂在链脲佐菌素和高脂饮食诱导的代谢功能障碍相关脂肪性肝病/代谢功能障碍相关脂肪性肝炎模型中可减轻肝脏炎症和纤维化。
Biomedicines. 2023 Dec 4;11(12):3216. doi: 10.3390/biomedicines11123216.

引用本文的文献

1
Dietary Strategies in the Prevention of MASLD: A Comprehensive Review of Dietary Patterns Against Fatty Liver.预防代谢相关脂肪性肝病的饮食策略:针对脂肪肝的饮食模式综合综述
Metabolites. 2025 Aug 4;15(8):528. doi: 10.3390/metabo15080528.

本文引用的文献

1
Association of food intake with a risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.食物摄入量与代谢功能障碍相关脂肪性肝病风险的关联:一项横断面研究。
Gastroenterol Rep (Oxf). 2023 Sep 11;11:goad054. doi: 10.1093/gastro/goad054. eCollection 2023.
2
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.肿瘤坏死因子-α在非酒精性脂肪性肝病发病机制和治疗中的作用。
Curr Obes Rep. 2023 Sep;12(3):191-206. doi: 10.1007/s13679-023-00519-y. Epub 2023 Jul 5.
3
Lifestyle interventions in nonalcoholic fatty liver disease.
非酒精性脂肪性肝病的生活方式干预。
Nat Rev Gastroenterol Hepatol. 2023 Nov;20(11):708-722. doi: 10.1038/s41575-023-00800-4. Epub 2023 Jul 4.
4
Cheese consumption and multiple health outcomes: an umbrella review and updated meta-analysis of prospective studies.奶酪消费与多种健康结局:前瞻性研究的伞式综述和更新的荟萃分析。
Adv Nutr. 2023 Sep;14(5):1170-1186. doi: 10.1016/j.advnut.2023.06.007. Epub 2023 Jun 15.
5
Dairy product consumption and risk of non-alcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.乳制品消费与非酒精性脂肪性肝病风险:观察性研究的系统评价和荟萃分析
Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1461-1471. doi: 10.1016/j.numecd.2023.04.018. Epub 2023 May 3.
6
Research advances of advanced glycation end products in milk and dairy products: Formation, determination, control strategy and immunometabolism via gut microbiota.牛奶及乳制品中晚期糖基化终产物的研究进展:通过肠道微生物群的形成、测定、控制策略及免疫代谢
Food Chem. 2023 Aug 15;417:135861. doi: 10.1016/j.foodchem.2023.135861. Epub 2023 Mar 5.
7
Effect of milk fat and its main fatty acids on oxidation and glycation level of milk.乳脂肪及其主要脂肪酸对牛奶氧化和糖化水平的影响。
J Food Sci Technol. 2023 Feb;60(2):720-731. doi: 10.1007/s13197-022-05658-z. Epub 2022 Dec 26.
8
Effects of Different Vegetable Oils on the Nonalcoholic Fatty Liver Disease in C57/BL Mice.不同植物油对C57/BL小鼠非酒精性脂肪性肝病的影响
Evid Based Complement Alternat Med. 2023 Jan 14;2023:4197955. doi: 10.1155/2023/4197955. eCollection 2023.
9
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
10
Non-alcoholic fatty liver disease and dairy products consumption: Results from FASA Persian cohort study.非酒精性脂肪性肝病与乳制品消费:来自FASA波斯队列研究的结果
Front Nutr. 2022 Sep 9;9:962834. doi: 10.3389/fnut.2022.962834. eCollection 2022.